110893 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Avulavirus, e.g. Newcastle disease virus Viruses as such, e.g. new isolates, mutants or their genomic sequences
Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same
#2RECOMBINANT VACCINE AGAINST COVID-19 TO PRODUCE CELLULAR RESPONSE IN INDIVIDUALS WITH PRE-EXISTING IMMUNITY
#3RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING LASSA VIRUS GP OR NP, AND USES THEREOF
#4RECOMBINANT PROTEIN FOR DISPLAYING S PROTEIN OF SARS-COV-2, RECOMBINANT VIRION, AND USE THEREOF
#5RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#6RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD THEREFOR, RECOMBINANT PLASMID, AND USE THEREOF
#7RECOMBINANT NEWCASTLE DISEASE VIRUS RNDV-VEGF-TRAP, GENOME THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF
#8RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD THEREFOR, RECOMBINANT PLASMID, AND USE THEREOF
#9RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED ACTIVITY
#10RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF
#11Oncolytic virus for colorectal cancer treatment using colorectal cancer cell-specific infectious newcastle disease virus and composition for colorectal cancer treatment using same
#12Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#13NEW ONCOLYTIC NEWCASTLE DISEASE VIRUSES AND RECOMBINANT NDV STRAINS
#14RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED ACTIVITY
#15Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof
#16Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#17INCREASED ACTIVITY OF ONCOLYTIC NEWCASTLE DISEASE VIRUS
#18Newcastle disease viruses and uses thereof
#19Newcastle Disease Viruses and Uses Thereof
#20Altered avian virus for in-ovo inoculation and methods of use thereof
#21Newcastle Disease Viruses And Uses Thereof
#22Oncolytic heterologous recombinant newcastle disease virus, preparation method and application thereof
#23Immunogenic composition
#24Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector
#25Chimeric viruses presenting non-native surface proteins and uses thereof
#26Chimeric newcastle disease viruses and uses thereof
#27NEWCASTLE DISEASE VIRUSES AND USES THEREOF
#28Heat-resistant newcastle disease virus live vaccine vector system and use thereof
#29Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
#30Chimeric Newcastle disease viruses and uses thereof
#31Chimeric viruses presenting non-native surface proteins and uses thereof
#32Chimeric Newcastle disease viruses and uses thereof
#33Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer
#34Recombinant avian paramyxovirus vaccine and method for making and using thereof
#35Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
#36Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms
#37NS1/2-deficient respiratory syncytial virus and melanoma treatment